Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

POTASSIUM, MONOBASIC vs PRAMLINTIDE: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

POTASSIUM, MONOBASIC vs PRAMLINTIDE: Safety Overview

Metric POTASSIUM, MONOBASIC PRAMLINTIDE
Total FAERS Reports 149 332
Deaths Reported 38 4
Death Rate 25.5% 1.2%
Hospitalizations 40 19
Average Patient Age 56.1 yrs 58.6 yrs
% Female Patients 22.5% 75.3%
FDA Approval Date N/A Mar 16, 2005
Manufacturer Rising Pharma Holdings, Inc. AstraZeneca Pharmaceuticals LP
Route ORAL SUBCUTANEOUS
Marketing Status N/A Discontinued